Physician profile
Ashley Elizabeth Poirier
NPI 1548798663
$3,008.74
in general payments reported to CMS, 2019-2025
17 companies · $1,640 in 2025
The $1,640 reported for 2025 was more than what 97% of Registered Nurse providers received nationally (typical 2025 total: $73.55).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $247 · 2023: $448 · 2024: $674 · 2025: $1,640.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,762.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,761.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $488.04 | 2022-2025 | Evenity, Repatha, Tepezza |
| Abbvie INC. | $334.45 | 2022-2025 | |
| Alexion Pharmaceuticals, INC. | $325.94 | 2025 | Ultomiris |
| Axsome Therapeutics, INC. | $240.68 | 2024-2025 | Auvelity |
| Alnylam Pharmaceuticals INC. | $216.54 | 2023-2024 | Amvuttra, Givlaari |
| Gilead Sciences, INC. | $140.39 | 2025 | Yeztugo |
| Janssen Pharmaceuticals, INC | $134.59 | 2024 | Spravato |
| Lundbeck LLC | $124.99 | 2024 | Vyepti |
| Novo Nordisk INC | $122.06 | 2023 | Wegovy |
| Astellas Pharma US INC | $122.06 | 2025 | Veozah |
| Jazz Pharmaceuticals INC. | $122.06 | 2025 | |
| Teva Pharmaceuticals USA, INC. | $122.06 | 2025 | Uzedy |
| Bayer Healthcare Pharmaceuticals INC. | $116.87 | 2025 | |
| Astrazeneca Pharmaceuticals Lp | $103.19 | 2024 | Airsupra |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $101.10 | 2024 | Lifevest |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka Pharmaceutical Development & Commercialization, INC. | $100.80 | 2025 | Rexulti |
| Corcept Therapeutics | $92.92 | 2025 | Korlym |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashley Poirier listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.